Q2 2021 Holdings
Filed 2021-08-13 | 9 holdings | $537.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc.(DYN) | Common | 26818M108 | $104.2K | 4,951,303 | 19.4% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $94.0K | 3,665,787 | 17.5% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $74.7K | 4,284,172 | 13.9% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $70.8K | 2,271,177 | 13.2% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $66.5K | 4,050,865 | 12.4% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $43.4K | 3,130,267 | 8.1% |
| Oncorus, Inc. | Common | 68236R103 | $39.3K | 2,849,464 | 7.3% |
| Chiasma, Inc.(CHMA) | Common | 16706W102 | $27.1K | 5,736,296 | 5.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | Common | 76243J105 | $17.8K | 909,258 | 3.3% |